A Phase I Dose Escalation-Expansion Trial of Sunitinib Malate Plus Lutetium Lu 177 Dotatate (Lutathera) in Somatostatin Receptor Positive Pancreatic Neuroendocrine Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT05687123

Title field or adapter rule

{'original_value': 'A Phase I Dose Escalation-Expansion Trial of Sunitinib Malate Plus Lutetium Lu 177 Dotatate (Lutathera) in Somatostatin Receptor Positive Pancreatic Neuroendocrine Tumors', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:22.958233+00:00

Published At

2026-10-20T00:00:00+00:00

Record Updated At

2026-10-20

Source Retrieved At

2026-10-31T22:17:52.415050+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Metastatic Pancreatic Neuroendocrine Tumor", "Pancreatic Neoplasm", "Stage III Pancreatic Neuroendocrine Tumor AJCC v8", "Stage IV Pancreatic Neuroendocrine Tumor AJCC v8", "Unresectable Pancreatic Neuroendocrine Tumor"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-20", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT05687123"

protocolSection.identificationModule.officialTitle

"A Phase I Dose Escalation-Expansion Trial of Sunitinib Malate Plus Lutetium Lu 177 Dotatate (Lutathera) in Somatostatin Receptor Positive Pancreatic Neuroendocrine Tumors"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Metastatic Pancreatic Neuroendocrine Tumor (protocolSection.conditionsModule.conditions)
• Pancreatic Neoplasm (protocolSection.conditionsModule.conditions)
• Stage III Pancreatic Neuroendocrine Tumor AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IV Pancreatic Neuroendocrine Tumor AJCC v8 (protocolSection.conditionsModule.conditions)
• Unresectable Pancreatic Neuroendocrine Tumor (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Treatment (sunitinib malate, lutetium Lu 177 dotatate)'], 'description': 'Undergo a blood sample collection', 'name': 'Biospecimen Collection', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Treatment (sunitinib malate, lutetium Lu 177 dotatate)'], 'description': 'Undergo a CT scan', 'name': 'Computed Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Treatment (sunitinib malate, lutetium Lu 177 dotatate)'], 'description': 'Given IV', 'name': 'Lutetium Lu 177 Dotatate', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Treatment (sunitinib malate, lutetium Lu 177 dotatate)'], 'description': 'Undergo MRI', 'name': 'Magnetic Resonance Imaging', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Treatment (sunitinib malate, lutetium Lu 177 dotatate)'], 'description': 'Undergo a SSR PET/CT scan', 'name': 'Positron Emission Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Treatment (sunitinib malate, lutetium Lu 177 dotatate)'], 'description': 'Given PO', 'name': 'Sunitinib Malate', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Lutetium Lu 177 Dotatate (protocolSection.armsInterventionsModule.interventions[].name)
• Sunitinib Malate (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.